Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Fuchs Henry J
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   222,228    

Indirect Shares

  0      
Direct Value   $18,063,061    

Indirect Value

  $0      
Total Shares   222,228      
Total Value   $18,063,061      


Onyx Pharmaceuticals Inc
 $0 Biomarin Pharmaceutical Inc
 $17,448,765 Mirati Therapeutics, Inc.
 $614,296 Onyx Pharmaceuticals Inc
 $0 Biomarin Pharmaceutical Inc
 $17,448,765 Mirati Therapeutics, Inc.
 $614,296
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX EVP & Chief Medical Of... 2008-11-18 14,891 2006-05-15 0    Premium*  
            Ardea Biosciences Inc RDEA Director 2012-06-19 0 2007-12-05 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN President, Worldwide R&D 2024-03-15 196,872 2009-03-02 0    Premium*  
            Genomic Health Inc GHDX Director 2019-11-08 0 2014-04-01 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 2023-01-20 10,465 2020-01-03 0    Premium*  
* Premium Members only  

Records found :    294         Free Registration Required For Full Results.    Limit: 25

Download
  Page 10 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-02-24 4 OE $26.49 $397,350 D/D 15,000 143,442 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-03-15 4 D $83.57 $406,234 D/D (4,861) 146,448 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2023-03-15 4 D $87.74 $421,064 D/D (4,799) 224,187 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2020-03-20 4 D $73.05 $426,320 D/D (5,836) 139,869 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2014-11-10 4 OE $21.51 $430,200 D/D 20,000 96,550 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-11-05 4 AS $46.00 $460,000 D/D (10,000) 52,277 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-03-22 4 D $81.36 $472,864 D/D (5,812) 156,676 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-03-15 4 D $92.50 $473,230 D/D (5,116) 120,402 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-03-22 4/A D $81.36 $474,736 D/D (5,835) 156,653 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2007-08-13 4 S $32.00 $480,478 D/D (15,000) 18,334 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-06-16 4 OE $26.49 $484,462 D/D 14,397 150,819 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-09-15 4 OE $26.49 $507,050 D/D 15,000 151,422 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-01-02 4 OE $26.49 $507,050 D/D 15,000 148,976 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2019-03-22 4 D $88.05 $513,860 D/D (5,836) 130,468 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2019-03-25 4 AS $87.86 $521,186 D/D (5,932) 124,536 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2007-08-30 4 OE $21.01 $525,250 D/D 25,000 42,292 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2008-05-16 4 OE $21.01 $525,250 D/D 25,000 41,975 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2008-05-29 4 OE $21.01 $525,250 D/D 25,000 41,975 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2008-08-14 4 OE $21.01 $525,250 D/D 25,000 41,975 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2021-03-15 4 D $78.39 $584,789 D/D (7,460) 110,855 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2013-05-23 4 AS $67.16 $584,981 D/D (8,710) 44,364 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2013-07-01 4 AS $60.00 $600,000 D/D (10,000) 43,266 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-07-02 4 AS $40.00 $602,808 D/D (15,000) 52,277 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2014-08-05 4 AS $65.00 $650,000 D/D (10,000) 76,550 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2014-02-03 4 AS $67.70 $676,966 D/D (10,000) 42,350 0 -

  294  Records found
  1   2   3   4   5   6   7   8   9   10  11   12      
  Page 10 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed